{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:46:38Z","timestamp":1765295198592,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007311","name":"Deutsche Kinderkrebsstiftung","doi-asserted-by":"publisher","award":["DKS2017.02"],"award-info":[{"award-number":["DKS2017.02"]}],"id":[{"id":"10.13039\/501100007311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GM1909A"],"award-info":[{"award-number":["01GM1909A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p> In children with cancer, specific clinical features such as physical anomalies, occurrence of cancer in young relatives, specific cancer histologies, and unique mutation\/methylation signatures may indicate the presence of an underlying cancer predisposition syndrome (CPS). The proportion of children with a cancer type suggesting a CPS among all children with cancer is unknown. To determine the proportion of children with cancer types suggesting an underlying CPS among children with cancer. We evaluated the number of children with cancer types strongly associated with CPS diagnosed in Germany between 2007 and 2016. Data were obtained from various sources including two national pediatric pathology reference laboratories for brain and solid tumors, respectively, various childhood cancer trial offices as well as the German Childhood Cancer Registry. Among 21,127 children diagnosed with cancer between 2007 and 2016, 2554 (12.1%) had a cancer type strongly associated with a CPS. The most common diagnoses were myelodysplastic syndrome and juvenile myelomonocytic leukemia, retinoblastoma, malignant peripheral nerve sheath tumor, infantile myofibromatosis, medulloblastoma<jats:sup>SHH<\/jats:sup>, rhabdoid tumor as well as atypical teratoid\/rhabdoid tumor. Based on cancer type only, 12.1% of all children with cancer have an indication for a genetic evaluation. Pediatric oncology patients require access to genetic counselling and testing.<\/jats:p>","DOI":"10.1007\/s10689-021-00234-4","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T04:38:16Z","timestamp":1614314296000},"page":"273-277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Proportion of children with cancer that have an indication for genetic counseling and testing based on the cancer type irrespective of other features"],"prefix":"10.1007","volume":"20","author":[{"given":"Thi Minh Kha","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Behnert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Pietsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Vokuhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4120-5873","authenticated-orcid":false,"given":"Christian Peter","family":"Kratz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"issue":"12","key":"234_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1136\/jmedgenet-2018-105488","volume":"55","author":"DE Sylvester","year":"2018","unstructured":"Sylvester DE, Chen Y, Jamieson RV, Dalla-Pozza L, Byrne JA (2018) Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature. J Med Genet 55(12):785\u2013793. https:\/\/doi.org\/10.1136\/jmedgenet-2018-105488","journal-title":"J Med Genet"},{"issue":"24","key":"234_CR2","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","volume":"373","author":"J Zhang","year":"2015","unstructured":"Zhang J, Walsh MF, Wu G et al (2015) Germline mutations in predisposition genes in pediatric cancer. N Engl J Med 373(24):2336\u20132346. https:\/\/doi.org\/10.1056\/NEJMoa1508054","journal-title":"N Engl J Med"},{"issue":"7696","key":"234_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature25480","volume":"555","author":"SN Grobner","year":"2018","unstructured":"Grobner SN, Worst BC, Weischenfeldt J et al (2018) The landscape of genomic alterations across childhood cancers. Nature 555(7696):321\u2013327. https:\/\/doi.org\/10.1038\/nature25480","journal-title":"Nature"},{"key":"234_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejca.2017.04.021","volume":"80","author":"FAM Postema","year":"2017","unstructured":"Postema FAM, Hopman SMJ, Aalfs CM et al (2017) Childhood tumours with a high probability of being part of a tumour predisposition syndrome; reason for referral for genetic consultation. Eur J Cancer 80:48\u201354. https:\/\/doi.org\/10.1016\/j.ejca.2017.04.021","journal-title":"Eur J Cancer"},{"issue":"3","key":"234_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ejmg.2016.01.008","volume":"59","author":"MC Jongmans","year":"2016","unstructured":"Jongmans MC, Loeffen JL, Waanders E et al (2016) Recognition of genetic predisposition in pediatric cancer patients: an easy-to-use selection tool. Eur J Med Genet 59(3):116\u2013125. https:\/\/doi.org\/10.1016\/j.ejmg.2016.01.008","journal-title":"Eur J Med Genet"},{"issue":"4","key":"234_CR6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/ajmg.a.38142","volume":"173","author":"T Ripperger","year":"2017","unstructured":"Ripperger T, Bielack SS, Borkhardt A et al (2017) Childhood cancer predisposition syndromes-a concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. Am J Med Genet A 173(4):1017\u20131037. https:\/\/doi.org\/10.1002\/ajmg.a.38142","journal-title":"Am J Med Genet A"},{"issue":"12","key":"234_CR7","doi-asserted-by":"publisher","first-page":"e27390","DOI":"10.1002\/pbc.27390","volume":"65","author":"C Goudie","year":"2018","unstructured":"Goudie C, Cullinan N, Villani A et al (2018) Retrospective evaluation of a decision-support algorithm (MIPOGG) for genetic referrals for children with neuroblastic tumors. Pediatr Blood Cancer 65(12):e27390. https:\/\/doi.org\/10.1002\/pbc.27390","journal-title":"Pediatr Blood Cancer"},{"key":"234_CR8","unstructured":"Kaatsch P, Grabow D, Spix C (2018) German Childhood Cancer Registry - Annual Report 2017 (1980\u20132016). Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz, 2018"},{"issue":"6","key":"234_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1470-2045(18)30242-0","volume":"19","author":"SM Waszak","year":"2018","unstructured":"Waszak SM, Northcott PA, Buchhalter I et al (2018) Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol 19(6):785\u2013798. https:\/\/doi.org\/10.1016\/S1470-2045(18)30242-0","journal-title":"Lancet Oncol"},{"issue":"1","key":"234_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-019-0063-6","volume":"5","author":"PA Northcott","year":"2019","unstructured":"Northcott PA, Robinson GW, Kratz CP et al (2019) Medulloblastoma. Nat Rev Dis Primers 5(1):11. https:\/\/doi.org\/10.1038\/s41572-019-0063-6","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"234_CR11","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1038\/leu.2017.121","volume":"31","author":"M Rasche","year":"2017","unstructured":"Rasche M, von Neuhoff C, Dworzak M et al (2017) Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004. Leukemia 31(12):2807\u20132814. https:\/\/doi.org\/10.1038\/leu.2017.121","journal-title":"Leukemia"},{"issue":"6","key":"234_CR12","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/pbc.20698","volume":"47","author":"S Aretz","year":"2006","unstructured":"Aretz S, Koch A, Uhlhaas S et al (2006) Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations? Pediatr Blood Cancer 47(6):811\u2013818. https:\/\/doi.org\/10.1002\/pbc.20698","journal-title":"Pediatr Blood Cancer"},{"issue":"19","key":"234_CR13","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1812169","volume":"380","author":"M Apellaniz-Ruiz","year":"2019","unstructured":"Apellaniz-Ruiz M, Segni M, Kettwig M et al (2019) Mesenchymal Hamartoma of the Liver and DICER1 Syndrome. N Engl J Med 380(19):1834\u20131842. https:\/\/doi.org\/10.1056\/NEJMoa1812169","journal-title":"N Engl J Med"},{"issue":"5","key":"234_CR14","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S2352-4642(19)30018-5","volume":"3","author":"S Mahamdallie","year":"2019","unstructured":"Mahamdallie S, Yost S, Poyastro-Pearson E et al (2019) Identification of new Wilms tumour predisposition genes: an exome sequencing study. Lancet Child Adolesc Health 3(5):322\u2013331. https:\/\/doi.org\/10.1016\/S2352-4642(19)30018-5","journal-title":"Lancet Child Adolesc Health"},{"issue":"4","key":"234_CR15","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/ijc.32167","volume":"145","author":"IJ Diets","year":"2019","unstructured":"Diets IJ, Hoyer J, Ekici AB et al (2019) TRIM28 haploinsufficiency predisposes to Wilms tumor. Int J Cancer 145(4):941\u2013951. https:\/\/doi.org\/10.1002\/ijc.32167","journal-title":"Int J Cancer"},{"issue":"6","key":"234_CR16","doi-asserted-by":"publisher","first-page":"e1007399","DOI":"10.1371\/journal.pgen.1007399","volume":"14","author":"BJ Halliday","year":"2018","unstructured":"Halliday BJ, Fukuzawa R, Markie DM et al (2018) Germline mutations and somatic inactivation of TRIM28 in Wilms tumour. PLoS Genet 14(6):e1007399. https:\/\/doi.org\/10.1371\/journal.pgen.1007399","journal-title":"PLoS Genet"},{"issue":"12","key":"234_CR17","doi-asserted-by":"publisher","first-page":"e0208936","DOI":"10.1371\/journal.pone.0208936","volume":"13","author":"AE Armstrong","year":"2018","unstructured":"Armstrong AE, Gadd S, Huff V, Gerhard DS, Dome JS, Perlman EJ (2018) A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: a Children\u2019s Oncology Group study. PLoS ONE 13(12):e0208936. https:\/\/doi.org\/10.1371\/journal.pone.0208936","journal-title":"PLoS ONE"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-021-00234-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-021-00234-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-021-00234-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T07:44:09Z","timestamp":1632987849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-021-00234-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,26]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["234"],"URL":"https:\/\/doi.org\/10.1007\/s10689-021-00234-4","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"type":"print","value":"1389-9600"},{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2021,2,26]]},"assertion":[{"value":"12 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors indicate no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethical review board at Hannover Medical School.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"A consent was not necessary in this retrospective analysis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and for publication"}}]}}